These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27257048)

  • 1. Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?
    Wynter J; Stine JG; Shah NL
    Dig Liver Dis; 2016 Sep; 48(9):1101. PubMed ID: 27257048
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?".
    Vanni E; Bugianesi E; Saracco GM
    Dig Liver Dis; 2016 Sep; 48(9):1101-2. PubMed ID: 27443491
    [No Abstract]   [Full Text] [Related]  

  • 3. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer?
    Jiang JF; Sun J; Shi J; Liu X
    Aliment Pharmacol Ther; 2017 Mar; 45(5):757-758. PubMed ID: 28150455
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C Virus and Antiviral Drug Resistance.
    Kim S; Han KH; Ahn SH
    Gut Liver; 2016 Nov; 10(6):890-895. PubMed ID: 27784846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-atherosclerotic cardiac manifestations of chronic hepatitis C virus infection in the era of direct-acting antiviral agents.
    Karimi-Sari H; Rezaee-Zavareh MS
    Atherosclerosis; 2020 Apr; 298():70. PubMed ID: 32147149
    [No Abstract]   [Full Text] [Related]  

  • 7. [Direct-acting antiviral treatment of chronic hepatitis C infection].
    Grüner N; Gerbes A
    MMW Fortschr Med; 2015 Apr; 157(8):57-60. PubMed ID: 26012687
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct-acting antiviral treatment for hepatitis C.
    Holmes JA; Rutledge SM; Chung RT
    Lancet; 2019 Apr; 393(10179):1392-1394. PubMed ID: 30765125
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: should direct-acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus-infected patients with cancer? Authors' reply.
    Economides MP; Shigle TL; Torres HA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):758-759. PubMed ID: 28150452
    [No Abstract]   [Full Text] [Related]  

  • 10. New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis.
    Ou P; Li F; Chen J
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1669-1671. PubMed ID: 27329403
    [No Abstract]   [Full Text] [Related]  

  • 11. Concerns About Direct-Acting Antiviral Agents for Hepatitis C-Cause for Reassurance.
    Beste LA
    JAMA Netw Open; 2019 Jun; 2(6):e194757. PubMed ID: 31173111
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging complexities with hepatitis C virus direct-acting antiviral regimens: Less is still Way more.
    Hill LA; Wyles DL
    Hepatology; 2016 Nov; 64(5):1401-1403. PubMed ID: 27635632
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.
    Maan R; Feld JJ; Duarte-Rojo A
    Aliment Pharmacol Ther; 2017 Aug; 46(3):379-380. PubMed ID: 28677289
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Ohashi H; Koizumi Y; Fukano K; Wakita T; Perelson AS; Iwami S; Watashi K
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4527-E4529. PubMed ID: 28512226
    [No Abstract]   [Full Text] [Related]  

  • 16. General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.
    Sud R; Tiwari N; Forner P; Dowdell L; Freiman J; Zekry A
    Intern Med J; 2018 Jan; 48(1):105-106. PubMed ID: 29314510
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-acting antiviral therapy for hepatitis E virus?
    Kamar N; Wang W; Dalton HR; Pan Q
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):154-155. PubMed ID: 28404127
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.
    Savale L; Chaumais MC; Montani D; Jaïs X; Hezode C; Antonini TM; Coilly A; Duclos-Vallée JC; Samuel D; Simonneau G; Humbert M; Sitbon O
    Chest; 2016 Jul; 150(1):256-8. PubMed ID: 27396788
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up.
    Fabrizi F; Aghemo A; Lampertico P; Fraquelli M; Cresseri D; Moroni G; Passerini P; Donato FM; Messa P
    Int J Artif Organs; 2018 Jun; 41(6):306-318. PubMed ID: 29595085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation after direct-acting antivirals for chronic hepatitis C infection.
    Thibault V
    Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):145-147. PubMed ID: 29371018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.